United Therapeutics
UTHR
UTHR
401 hedge funds and large institutions have $7.77B invested in United Therapeutics in 2021 Q2 according to their latest regulatory filings, with 54 funds opening new positions, 117 increasing their positions, 159 reducing their positions, and 40 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.58% less ownership
Funds ownership: 97.58% → 97% (-0.58%)
19% less funds holding in top 10
Funds holding in top 10: 16 → 13 (-3)
26% less repeat investments, than reductions
Existing positions increased: 117 | Existing positions reduced: 159
Holders
401
Holding in Top 10
13
Calls
$48.6M
Puts
$22.8M
Top Buyers
1 | +$99.1M | |
2 | +$79.3M | |
3 | +$50.1M | |
4 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$42.4M |
5 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$39.6M |
Top Sellers
1 | -$71.6M | |
2 | -$52.5M | |
3 | -$45.5M | |
4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$43.8M |
5 |
![]()
Fidelity Investments
Boston,
Massachusetts
|
-$31.8M |